Market

Lupin launches generic favipiravir, Covihalt to treat coronavirus infection

Read more

Zenara Pharma, a Biophore subsidiary, gets DCGI nod for favipiravir tablets 

Read more

Converge Biotech launches Vergiflu (favipiravir) for COVID-19 treatment

Read more

Lupin gets tentative approval from US FDA for empagliflozin tablets

Read more

Sun Pharma launches generic favipiravir, FluGuard at Rs 35 per tablet

Read more

US FDA approves SPRAVATO, antidepressant medication from J&J

Read more

Vopec Pharma completes COVID-19 clinical trials of herbal formulation, Amrta Karuna

Read more

Jubilant Life Sciences launches JUBI-R for COVID-19 treatment

Read more

Rozlytrek from Roche gets EC approval to treat solid tumours and NSCLC

Read more

Wockhardt signs partnership with UK Government to fill-finish COVID-19 vaccine

Read more